Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity April 2, 1995
Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens January 1, 1986
Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca April 1, 1984
